Bronchiectasis following treatment for high-risk neuroblastoma: A case series-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bronchiectasis following treatment for high-risk neuroblastoma: A case series

Published:2017-03-10 Issue:10 Volume:64 Page:e26509
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Adams Madeleine¹,Traunecker Heidi²,Doull Iolo³,Cox Rachel⁴

Affiliation:

1. Department of Paediatric Oncology; Children's Hospital for Wales; Heath Park Cardiff UK

2. Department of Paediatric Oncology; Children's Hospital for Wales; Cardiff UK

3. Department of Paediatric Respiratory Medicine; Children's Hospital for Wales; Cardiff UK

4. Department of Paediatric Oncology; Bristol Children's Hospital; Bristol UK

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference24 articles.

1. Non-cystic fibrosis bronchiectasis;Al Subie;J Paediatr Child Health,2012

2. Bronchiectasis secondary to primary immunodeficiency in children: longitudinal changes in structure and function;Haidopoulou;Pediatr Pulmonol,2009

3. Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: high incidence of endocrine and growth problems;Cohen;Bone Marrow Transplantation,2014

4. Long-term follow-up of children with high-risk neuroblastoma: the ENSG5 trial experience;Moreno;Pediatr Blood Cancer,2013

5. Risk of hospitalization for survivors of childhood and adolescent cancer;Kirchhoff;Cancer Epidemiol Biomarkers Prev,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era;Current Oncology Reports;2019-11-25

2. Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high‐risk neuroblastoma;Pediatric Blood & Cancer;2019-08-12

3. Current Pharmacotherapy for Neuroblastoma;Neuroblastoma;2019

4. Late Effects and Survivorship Issues in Patients with Neuroblastoma;Children;2018-08-06

5. Busulfan/melphalan;Reactions Weekly;2017-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3